Approval · Notice of Compliance 31900 · 2023
CLASTEON: Notice of Compliance 31900
Issued October 18, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 31900
- Date
- October 18, 2023
- Company
- Sumitomo Pharma Canada, Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative: Manufacturer Name Change
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CLASTEON | 02245828 | Marketed |
Medicinal ingredients
- CLODRONATE DISODIUM 400 MG per CAP